Compare FRME & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRME | CNTA |
|---|---|---|
| Founded | 1893 | 2020 |
| Country | United States | United Kingdom |
| Employees | 2120 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.5B |
| IPO Year | N/A | 2021 |
| Metric | FRME | CNTA |
|---|---|---|
| Price | $36.75 | $28.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $48.33 | $40.89 |
| AVG Volume (30 Days) | 399.4K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.77 | N/A |
| Revenue Next Year | $5.87 | N/A |
| P/E Ratio | $10.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.29 | $9.60 |
| 52 Week High | $43.22 | $30.58 |
| Indicator | FRME | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.83 | 64.71 |
| Support Level | $34.93 | $24.62 |
| Resistance Level | $37.03 | $30.29 |
| Average True Range (ATR) | 1.05 | 1.27 |
| MACD | -0.32 | 0.15 |
| Stochastic Oscillator | 14.17 | 96.98 |
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.